9302例子宫相关恶性肿瘤患者病案随访数据分析  

Analysis of Medical Records of 9,302 Patients with Uterine Malignancies

作　　者：王凯鹏 杨爱萍 杨景芳 马宇娇 霍宇艳 刘爽 Wang Kaipeng;Yang Aiping;Yang Jingfang;Ma Yujiao;Huo Yuyan;Liu Shuang(Medical Records Department,Cancer Hospital,Chinese Academy of Medical Sciences,Beijing 100021,China;不详)

机构地区：[1]国家癌症中心,国家肿瘤临床医学研究中心,中国医学科学院北京协和医学院肿瘤医院病案室,北京市100021

出　　处：《中国病案》2025年第3期1-4,83,共5页Chinese Medical Record

摘　　要：目的分析某三级甲等肿瘤专科医院子宫相关恶性肿瘤患者构成与随访结果数据质量,为临床研究和防治提供参考。方法选取2009年1月1日—2018年12月31日某院收治且获得完整随访资料的9302例子宫相关恶性肿瘤患者病案随访数据,采用χ^(2)检验和Cochran-Armitage趋势性检验,分析构成特征及变化趋势。结果子宫相关恶性肿瘤患者5年期总体生存率为71.2%,生存率随年龄的升高呈现下降趋势,其中≥70岁的患者年龄组生存率最低。子宫体的患者生存率最高,子宫未特指部位生存率最低。鳞状细胞癌的生存率为72.3%,腺癌的生存率为73.4%。Ⅰ期肿瘤生存率最高,Ⅳ期肿瘤生存率最低。比较不同首次治疗方式的随诊结果数据,其中根治术的患者生存率最高,放射治疗生存率最低。结论2009-2018年间的子宫相关恶性肿瘤患者总体有效随访率大于90%,随访生存率稳定,与肿瘤分期、肿瘤病理及首次治疗方式等肿瘤预后的相关报道一致,病案随访数据质量可靠。Objectives This study aims to analyze the composition of patients with uterine-related malignant tumors and the quality of follow-up data in a tertiary-level A-class cancer hospital.Methods The follow-up data of 9,302 patients with uterine-related malignant tumors who were admitted to a hospital from January 1,2009 to December 31,2018 and had complete follow-up information were selected to analyze the composition characteristics and changing trends.Results The 5-year overall survival rate of patients with uterine-related malignant tumors was 71.2%.The survival rate showed a downward trend with increasing age,among which the survival rate was the lowest in the patient age group 70 years and above.Among tumor locations,patients with uterine corpus had the highest survival rate,while patients with unspecified uterine sites had the lowest survival rate.Among the tumor pathological types,the survival rate of squamous cell carcinoma was 72.3%,and the survival rate of adenocarcinoma was 73.4%.The survival rate was highest for stage Ⅰ tumors and lowest for stage Ⅳ tumors.Comparing the follow-up outcome data of different first treatment methods,the survival rate of patients treated with radical surgery was the highest,while the survival rate of patients treated with radiotherapy was the lowest.Conclusions The overall effective follow-up rate of patients with uterine-related malignant tumors between 2009 and 2018 was greater than 90%,and the follow-up survival rate was stable,which was consistent with relevant reports on tumor prognosis such as tumor staging,tumor pathology and first treatment method.The quality of medical record follow-up data was reliable.

关 键 词：子宫恶性肿瘤 病案 随访 疾病构成 生存分析 

分 类 号：R737.33[医药卫生—肿瘤]